‘India’s biotech sector to grow 20%’https://indianexpress.com/article/news-archive/web/indias-biotech-sector-to-grow-20/

‘India’s biotech sector to grow 20%’

Biofuels would also offer a huge growth opportunity in biotech,Kiran Mazumdar-Shaw said.

India’s biotech sector is expected to grow at a robust 20 per cent per annum in the near future,given the growing demand for biopharmaceuticals,biosimilars and vaccines,says a veteran in the field.

Biofuels would also offer a huge growth opportunity in biotech,the Chairman and Managing Director of Biocon,the country’s largest biotech company by revenue,Kiran Mazumdar-Shaw said.

“We are entering the era of bioeconomy,where biotechnology can provide powerful solutions to some of the grave challenges that we face today: food scarcity,energy deficit,environmental damage,unmet medical needs and industrial pollution,” she said.

Mazumdar-Shaw said the size of the country’s biotech sector had reached USD 3.5 billion in 2010 and is poised for robust growth in all segments of biotechnology.

Advertising

“India is already a world leader in vaccine production,Bt Cotton and bio-pharmaceuticals,especially bio-similars,” she said. “India is also a large producer of industrial enzymes for green technologies & bioremediation. We also have critical mass in tissue culture-based cultivation.”

However,Mazumdar-Shaw also referred to regulatory delays,import-export delays and restrictions,lack of venture funding and the listing norms that are unfavourable to innovation-led biotech companies.

“The inherent risk associated with gestational time lines involved in developing biotech products is a huge deterrent for investors. Example,Bt Brinjal”,she pointed out.

Asked about her vision for Bangalore-headquartered Biocon,Mazumdar-Shaw,who has been named among TIME magazine’s 100 most influential people in the world,said: “I am committed to pursuing our strategy of delivering affordable drugs for global markets that make a difference to healthcare.”